Perioperative heart-type fatty acid binding protein levels in atrial fibrillation after cardiac surgery

Heart Rhythm

Volumn 10, Issue 2, 2013, Pages 153-157

  Rader, Florian ^a   Pujara, Akshat C ^b   Pattakos, Gregory ^c   Rajeswaran, Jeevanantham ^c   Li, Liang ^c   Castel, Laurie ^c   Chung, Mina K ^c   Marc Gillinov, A ^c   Costantini, Otto ^b   Van Wagoner, David R ^c   Blackstone, Eugene H ^c  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Atrial fibrillation; Biomarker; CABG; Ischemia; Postoperative; Valve surgery

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; FATTY ACID BINDING PROTEIN; HEART TYPE FATTY ACID BINDING PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORONARY ARTERY BYPASS SURGERY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROUPS BY AGE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART VALVE SURGERY; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PATHOPHYSIOLOGY; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TELEMETRY;

AGED; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; COHORT STUDIES; CORONARY ARTERY BYPASS; CORONARY DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FATTY ACID-BINDING PROTEINS; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MIDDLE AGED; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84873602775     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2012.10.007     Document Type: Article

References (26)

1. J.P. Mathew, M.L. Fontes, and I.C. Tudor Investigators of the Ischemia Research and Education Foundation, Multicenter Study of Perioperative Ischemia Research Group. A multicenter risk index for atrial fibrillation after cardiac surgery JAMA 291 2004 1720 1729
2. C.R. Asher, D.P. Miller, R.A. Grimm, D.M. Cosgrove III, and M.K. Chung Analysis of risk factors for development of atrial fibrillation early after cardiac valvular surgery Am J Cardiol 82 1998 892 895
3. S.F. Aranki, D.P. Shaw, and D.H. Adams Predictors of atrial fibrillation after coronary artery surgery: current trends and impact on hospital resources Circulation 94 1996 390 397
4. L.B. Mitchell, D.V. Exner, and D.G. Wyse Prophylactic oral amiodarone for the prevention of arrhythmias that begin early after revascularization, valve replacement, or repair. PAPABEAR: a randomized controlled trial JAMA 294 2005 3093 3100
5. D.M. Gallik, I. Singer, M.D. Meissner, J. Molnar, and J.C. Somberg Hemodynamic and surface electrocardiographic effects of a new aqueous formulation of intravenous amiodarone Am J Cardiol 90 2002 964 968
6. S.H. Taylor, B. Silke, and P.S. Lee Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful? N Engl J Med 306 1982 631 635
7. B.N. Singh, R.M. Whitlock, R.H. Comber, F.H. Williams, and E.A. Harris Effects of cardioselective beta adrenoceptor blockade on specific airways resistance in normal subjects and in patients with bronchial asthma Clin Pharmacol Ther 19 1976 493 501
8. C.D. Bayliff, D.R. Massel, and R.I. Inculet Propranolol for the prevention of postoperative arrhythmias in general thoracic surgery Ann Thorac Surg 67 1999 182 186
9. H.M. Azzazy, M.M. Pelsers, and R.H. Christenson Unbound free fatty acids and heart-type fatty acid-binding protein: diagnostic assays and clinical applications Clin Chem 52 2006 19 29
10. K. Viswanathan, N. Kilcullen, and C. Morrell Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative J Am Coll Cardiol 55 2010 2590 2598
11. P. Diggle, P. Heagerty, K. Liang, and S. Zeger Analysis of Longitudinal Data 2nd ed 2002 Oxford University Press New York
12. E.H. Blackstone Breaking down barriers: helpful breakthrough statistical methods you need to understand better J Thorac Cardiovasc Surg 122 2001 430 439
13. D.P. Mason, J. Rajeswaran, and S.C. Murthy Spirometry after transplantation: how much better are two lungs than one? Ann Thorac Surg 85 2008 1193 1201 1201.e1-e2
14. J.F. Glatz, and G.J. van der Vusse Cellular fatty acid-binding proteins: their function and physiological significance Prog Lipid Res 35 1996 243 282
15. H.M. Piper, P. Schwartz, R. Spahr, J.F. Hutter, and P.G. Spieckermann Early enzyme release from myocardial cells is not due to irreversible cell damage J Mol Cell Cardiol 16 1984 385 388
16. J.F. Glatz, A.H. Kleine, F.A. van Nieuwenhoven, W.T. Hermens, M.P. van Dieijen-Visser, and G.J. van der Vusse Fatty-acid-binding protein as a plasma marker for the estimation of myocardial infarct size in humans Br Heart J 71 1994 135 140
17. E. Rechavia, B. Strasberg, and A. Mager The incidence of atrial arrhythmias during inferior wall myocardial infarction with and without right ventricular involvement Am Heart J 124 1992 387
18. T.J. Bunch, K. Chandrasekaran, and B.J. Gersh The prognostic significance of exercise-induced atrial arrhythmias J Am Coll Cardiol 43 2004 1236
19. L. Jidéus, M. Kesek, and P.O. Joachimsson The role of premature atrial contractions as the main triggers of postoperative atrial fibrillation J Electrocardiol 39 2006 48
20. R. Ascione, M. Caputo, G. Calori, C.T. Lloyd, M.J. Underwood, and G.D. Angelini Predictors of atrial fibrillation after conventional and beating heart coronary surgery: a prospective, randomized study Circulation 102 2000 1530 1535
21. G. Palmer, M.A. Herbert, and S.L. Prince Coronary Artery Revascularization (CARE) registry: an observational study of on-pump and off-pump coronary artery revascularization Ann Thorac Surg 83 2007 986 991 discussion 991-992
22. V. Malik, S.C. Kale, U.K. Chowdhury, L. Ramakrishnan, S. Chauhan, and U. Kiran Myocardial injury in coronary artery bypass grafting: on-pump versus off-pump comparison by measuring heart-type fatty-acid-binding protein release Tex Heart Inst J 33 2006 321 327
23. J.D. Muehlschlegel, T.E. Perry, and K.Y. Liu Heart-type fatty acid binding protein is an independent predictor of death and ventricular dysfunction after coronary artery bypass graft surgery Anesth Analg 111 2010 1101 1109
24. R.H. Miles, R. Passman, and D.K. Murdock Comparison of effectiveness and safety of ranolazine versus amiodarone for preventing atrial fibrillation after coronary artery bypass grafting Am J Cardiol 108 2011 673 676
25. P.H. Stone, B.R. Chaitman, K. Stocke, J. Sano, A. DeVault, and G.G. Koch The anti-ischemic mechanism of action of ranolazine in stable ischemic heart disease J Am Coll Cardiol 56 2010 934 942
26. 2+ overload and oxidative stress and improves mitochondrial integrity to protect against ischemia reperfusion injury in isolated hearts Pharmacol Res 64 2011 381 392